Hypersecretion of calcitonin (Q39782): Difference between revisions

← Older edit

@@ Property / CURIE @@
+CID11:5A04
@@ Property / CURIE: CID11:5A04 / rank @@
+Normal rank
@@ Property / Canary Token @@
+dki-india-5A04
@@ Property / Canary Token: dki-india-5A04 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-13T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-13T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 13 August 2026 / rank @@
+Normal rank
@@ Property / Linked ICD 10 @@
+E07.0
@@ Property / Linked ICD 10: E07.0 / rank @@
+Normal rank

Latest revision as of 05:19, 13 August 2026

This is the process of elaborating, releasing, and oozing a 32-amino acid linear polypeptide hormone that is produced in humans primarily by the parafollicular cells (also known as C-cells) of the thyroid, and in many other animals in the ultimobranchial body.

Language	Label	Description	Also known as
default for all languages	5A04
English	Hypersecretion of calcitonin	This is the process of elaborating, releasing, and oozing a 32-amino acid linear polypeptide hormone that is produced in humans primarily by the parafollicular cells (also known as C-cells) of the thyroid, and in many other animals in the ultimobranchial body.